RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LGND
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Ligand Pharmaceuticals Incorporated stock upgraded to Buy Candidate.
(Updated on Mar 28, 2024)

Buy candidate since Mar 28, 2024 PDF

The Ligand Pharmaceuticals Incorporated stock price gained 2.57% on the last trading day (Thursday, 28th Mar 2024), rising from $71.27 to $73.10. During the last trading day the stock fluctuated 2.99% from a day low at $71.29 to a day high of $73.42. The price has been going up and down for this period, and there has been a 1.63% gain for the last 2 weeks. Volume fell on the last day by -82 thousand shares and in total, 104 thousand shares were bought and sold for approximately $7.63 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Ligand Pharmaceuticals Incorporated stock with a 90% probability to be traded between $69.06 and $89.92 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LGND Signals & Forecast

There are mixed signals in the stock today. The Ligand Pharmaceuticals Incorporated stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $74.10. On a fall, the stock will find some support from the short-term average at $71.33. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 6.50%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Ligand Pharmaceuticals Incorporated stock

Ligand Pharmaceuticals Incorporated finds support from accumulated volume at $71.93 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.13 between high and low, or 2.99%. For the last week, the stock has had daily average volatility of 3.39%.

Our recommended stop-loss: $70.51 (-3.54%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (LGND) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Ligand Pharmaceuticals Incorporated to open at $72.60, and during the day (based on 14 day Average True Range), to move between $70.28 and $75.92, which gives a possible trading interval of +/-$2.82 (+/-3.86%) up or down from last closing price. If Ligand Pharmaceuticals Incorporated takes out the full calculated possible swing range there will be an estimated 7.73% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $71.93 (1.60%) than the resistance at $79.35 (8.55%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Ligand Pharmaceuticals Incorporated stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Ligand Pharmaceuticals Incorporated stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.542 Buy Candidate Upgraded

Predicted Opening Price for Ligand Pharmaceuticals Incorporated of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$72.60 ( 0.679%) $73.10

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LGND

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 74.73 2.23 %
R2 73.92 1.12 %
R1 73.42 0.434 %
Current price: 73.10
Support S1 71.79 -1.79 %
S2 71.29 -2.48 %
S3 70.47 -3.59 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 89.20 22.02 %
R2 84.35 15.39 %
R1 79.35 8.55 %
Current price 73.10
Support S1 71.93 -1.60%
S2 71.09 -2.75%
S3 71.00 -2.87%

LGND Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 02, 2010 Jul 02, 2010 Jul 01, 2010 $0.456 5.43%
2 Mar 21, 2007 Apr 03, 2007 Apr 19, 2007 $9.36 21.97%

FAQ

What is the symbol for Ligand Pharmaceuticals Incorporated Stock and on which exchange is it traded?
The symbol for Ligand Pharmaceuticals Incorporated is LGND and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ligand Pharmaceuticals Incorporated Stock?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Ligand Pharmaceuticals Incorporated stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Ligand Pharmaceuticals Incorporated Stock?
Ligand Pharmaceuticals Incorporated Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ligand Pharmaceuticals Incorporated Stock.

What's the current price of Ligand Pharmaceuticals Incorporated Stock?
As of the end of day on the 2024-03-28, the price of an Ligand Pharmaceuticals Incorporated (LGND) share was $73.10.

What is the 52-week high and low for Ligand Pharmaceuticals Incorporated Stock?
The 52-week high for Ligand Pharmaceuticals Incorporated Stock is $94.57 and the 52-week low is $49.25.

What is the market capitalization of Ligand Pharmaceuticals Incorporated Stock?
As of the 2024-03-28, the market capitalization of Ligand Pharmaceuticals Incorporated is 1.294B.

When is the next earnings date for Ligand Pharmaceuticals Incorporated?
The upcoming earnings date for Ligand Pharmaceuticals Incorporated is May 02, 2024.
Click to get the best stock tips daily for free!

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticalsorporated Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease ca... LGND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT